Naba Alsaha Medical Services Company
9546.SRSAUHealthcare● Active
$22.85
+$0.45(+2.01%)
Market Cap$479850000
P/E Ratio—
52W High$34.65
52W Low$20.37
Naba Alsaha Medical Services Company (9546.SR) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 9546.SR · as of 2026-06-15
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.03B | $0.02B | $0.05B | $0.03B | $0.03B |
| Depreciation & Amort. | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Change in Working Capital | ($0.02B) | ($0.00B) | ($0.03B) | ($0.00B) | ($0.00B) |
| Net Cash from Operations | $0.03B | $0.04B | $0.03B | $0.04B | $0.03B |
| Investing Activities | |||||
| Capital Expenditure | ($0.08B) | ($0.04B) | ($0.04B) | ($0.01B) | ($0.01B) |
| Purchases of Investments | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.08B) | ($0.04B) | ($0.06B) | ($0.01B) | ($0.01B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) | $0.00B |
| Debt Issued / Repaid | $0.04B | $0.04B | $0.03B | ($0.01B) | ($0.01B) |
| Net Cash from Financing | $0.03B | $0.04B | $0.02B | ($0.01B) | ($0.02B) |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.05B) | ($0.00B) | ($0.01B) | $0.02B | $0.02B |
| FCF Margin %(computed) | -25.35% | -1.42% | -6.66% | 18.85% | 17.31% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · B
Explore more Naba Alsaha Medical Services Company data
About Naba Alsaha Medical Services Company (9546.SR) Cash Flow Statement
Naba Alsaha Medical Services Company generated operating cash flow of $0.03B and free cash flow of ($0.05B) for 2025 — a FCF margin of -25.35%. Capital expenditure was ($0.08B).
Frequently asked questions
9546.SR · 4 questionsNaba Alsaha Medical Services Company generated free cash flow of ($0.05B) for 2025, down 1758.7% year-over-year.
9546.SR free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15